{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-006219","form_type":"8-K","ticker":"TLPH","cik":"0001427925","company_name":"TALPHERA, INC.","filed_at":"2024-03-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.159580+00:00","generated_at":"2026-06-05T05:25:00.481539+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Talphera reduces board from 10 to 7; three directors resign; regains Nasdaq bid price compliance","bullets":["Directors Richard Afable, Howard Rosen, and Pamela Palmer resigned effective Feb 26-28, 2024, no disagreements.","Board size reduced from ten to seven directors; committees reconstituted with continuing members.","Nasdaq notified Talphera on Feb 27 that it regained compliance with $1.00 minimum bid price rule as of Feb 26, 2024.","Pamela Palmer remains Chief Medical Officer; focus on Niyad registrational study."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-006219","json":"https://secwatch.observer/filing/0001437749-24-006219.json","markdown":"https://secwatch.observer/filing/0001437749-24-006219.md","text":"https://secwatch.observer/filing/0001437749-24-006219.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1427925/000143774924006219/0001437749-24-006219-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1427925/000143774924006219/acrx20240229_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T05:25:00.481539+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a2eb5776ee","claim":"Howard B. Rosen resigned as Director at TALPHERA, INC..","evidence_excerpt":"On February 26, 2024, Richard Afable, M.D. and Howard B. Rosen resigned as members of the board of directors of Talphera, Inc. (the \"Company\"), and any and all committees thereof, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1427925/000143774924006219/0001437749-24-006219-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"c897e8e916","claim":"Richard Afable, M.D. resigned as Director at TALPHERA, INC..","evidence_excerpt":"On February 26, 2024, Richard Afable, M.D. and Howard B. Rosen resigned as members of the board of directors of Talphera, Inc. (the \"Company\"), and any and all committees thereof, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1427925/000143774924006219/0001437749-24-006219-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"d20b51f05a","claim":"Pamela P. Palmer, M.D., Ph.D. resigned as Director at TALPHERA, INC..","evidence_excerpt":"On February 28, 2024, Pamela P. Palmer, M.D., Ph.D. resigned as a member of the Company's board of directors effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1427925/000143774924006219/0001437749-24-006219-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}